OBJECTIVE: To determine the most effective, evidence-based approach to the use of platelet transfusions in patients with cancer. OUTCOMES: Outcomes of interest included prevention of morbidity and ...
Myelodysplastic syndromes (MDS) can damage bone marrow, lowering red blood cells and platelets. Transfusions replace missing cells to manage anemia or thrombocytopenia. Up to 9 in 10 people with MDS ...
Platelet transfusion thresholds in according bleeding risk and the presence of bleeding. WHO = World Health Organization. “In practice, we see all too often [that] prophylactic transfusion of ...
In addition to enabling the manufacture of platelets on demand, the finding could help doctors better treat both cancer and thrombocytopenia, a clotting disorder that often strikes newborns in ...
A shelf-stable, freeze-dried platelet product shows promise in treating TBI by reinforcing damaged blood vessels and reducing ...
A preliminary study published in this week's issue of THE LANCET suggests a possible explanation for the biological process responsible for inducing fever and related symptoms after the transfusion of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results